EOVIST
Active substance: gadoxetate disodium
INJECTION, SOLUTION · GADOXETATE DISODIUM 181.43 mg/mL
United StatesActive
Marketing holder: Bayer HealthCare Pharmaceuticals Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- GADOXETATE DISODIUM · 181.43 mg/mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12096-0403-792a-801a-57225551a0a5;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 50419-320
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 50419-320 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 50419-320 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 50419-320 · Verified 2026-10-09 · open in source